Oxoisoaporphine alkaloid derivative 8-1 reduces Aβ1-42 secretion and toxicity in human cell and Caenorhabditis elegans models of Alzheimer's disease

Alzheimer's disease (AD) is a multifactorial neurodegenerative disease and a growing health problem worldwide. Because the drugs currently used to treat AD have certain drawbacks such as single targeting, there is a need to develop novel multi-target compounds, among which oxoisoaporphine alkal...

Full description

Saved in:
Bibliographic Details
Published inNeurochemistry international Vol. 108; pp. 157 - 168
Main Authors Huang, Liyingzi, Luo, Yunfeng, Pu, Zhijun, Kong, Xianghui, Fu, Xiang, Xing, Huanhuan, Wei, Shenqi, Chen, Wei, Tang, Huang
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease (AD) is a multifactorial neurodegenerative disease and a growing health problem worldwide. Because the drugs currently used to treat AD have certain drawbacks such as single targeting, there is a need to develop novel multi-target compounds, among which oxoisoaporphine alkaloid derivatives are promising candidates. In this study, the possible anti-AD activities of 14 novel oxoisoaporphine alkaloid derivatives that we synthesized were screened and evaluated. We found that, in the 14 novel derivatives, compound 8-1 significantly reduced Aβ1-42 secretion in SH-SY5Y cells overexpressing the Swedish mutant form of human β-amyloid precursor protein (APPsw). Next, we found that compound 8-1 could down-regulate the expression level of β-amyloid precursor protein (APP) in APPsw cells. Moreover, compound 8-1 significantly delayed paralysis in the Aβ1-42-transgenic Caenorhabditis elegans strain GMC101, which could be explained by the fact that compound 8-1 down-regulated acetylcholinesterase activity, protected against H2O2-induced acute oxidative stress and paraquat-induced chronic oxidative stress, and enhanced autophagy activity. Taken together, our data suggest that compound 8-1 could attenuate the onset and development of AD. •Compound 8-1 reduced secreted Aβ1-42 level in APPsw cells which were SH-SY5Y cells overexpressing human β-amyloid precursor protein (APP).•Compound 8-1 delayed the paralysis in Aβ1-42-transgenic C. elegans GMC101.•Compound 8-1 could significantly protect Aβworms GMC101 against H2O2-induced acute oxidative stress and paraquat-induced chronic oxidative stress.•Compound 8-1 reduced AChE activity in Aβ1-42-transgenic C. elegans GMC101.•Compound 8-1 enhanced autophagy initiation gene bec-1 expression in GMC101 and could reduce autophagy substrate protein SQST-1 in BC12921.
ISSN:0197-0186
1872-9754
DOI:10.1016/j.neuint.2017.03.007